Wang et al. utilizing integrated meta-analysis approach have shown the oncogenic role of miRNA-27a by mediating FOXO1 and its inhibition could serve as a new strategy in combating ovarian cancer (Wang Z. et al., 2018, p. 1). Here, FOXO1 is linked to ovarian cancer.